Quick Answer
BALCHEM CORP reported Stockholders Equity of $1.26 billion for fiscal year 2025.
BALCHEM CORP Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $1.26B | +9.3% |
| 2024 | $1.15B | +9.1% |
| 2023 | $1.05B | +12.3% |
| 2022 | $938.28M | +7.0% |
| 2021 | $877.01M | +5.9% |
| 2020 | $828.23M | +11.4% |
| 2019 | $743.67M | +7.5% |
| 2018 | $691.62M | +12.1% |
| 2017 | $616.88M | +18.4% |
| 2016 | $521.03M | +12.4% |
| 2015 | $463.70M | +18.3% |
| 2014 | $391.90M | +18.3% |
| 2013 | $331.36M | +21.4% |
| 2012 | $273.01M | +17.7% |
| 2011 | $232.01M | +23.8% |
| 2010 | $187.47M | +27.4% |
| 2009 | $147.14M | +28.5% |
| 2008 | $114.51M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.30B | +10.2% | +2.4% |
| June 30, 2025 | $1.27B | +14.0% | +4.9% |
| March 31, 2025 | $1.21B | +12.0% | +5.1% |
| December 31, 2024 | $1.15B | +9.1% | -2.3% |
| September 30, 2024 | $1.18B | +14.8% | +5.8% |
| June 30, 2024 | $1.11B | +10.5% | +3.1% |
| March 31, 2024 | $1.08B | +10.8% | +2.4% |
| December 31, 2023 | $1.05B | +12.3% | +2.8% |
- BALCHEM CORP showed an increase of +9.3% in Stockholders Equity compared to the prior fiscal year.
- Over the 2008–2025 period, BALCHEM CORP’s stockholders equity has grown by 998.1% (from $114.51 million to $1.26 billion).
- The most recent figure is from BALCHEM CORP’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 20, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: